December 31, 2013, through the International Statistical Classification of Diseases, .
Control subjects (n = 246,978, 5 controls per case) were randomly selected from the national registry of the population through risk set sampling with replacement ( Fig. 1) . Control subjects were matched to case patients by birth year (age), sex, and geographic area of residence at the time of the case patients' MI diagnosis (index date), had no registered MI, and were alive at the case patients' index date. Geographical matching was performed since the incidence of MI and health care differ geographically in Sweden (Jernberg 2016) . The match by birth year explains the slight but, due to the large sample size, statistically significant difference in mean age (72.6 vs. 72.3 y) . Furthermore, the case-control match was performed before the data were linked to the IPR, and since control subjects with a previous MI diagnosis had then been excluded, this also contributed to the minor difference in age and sex between the groups.
Information Assessment
Information on exposure (invasive dental treatments), outcome (MI), and other variables of interest was individually obtained for each study subject from the National Board of Health and Welfare (NBHW) and Statistics Sweden (SCB) by way of the unique national personal identification number assigned to each Swedish resident at birth or immigration. After linkage, the personal identification number was coded to preserve anonymity.
Exposure was defined as one or several of the following invasive dental treatment procedures registered in the national registry of dental treatments, the Dental Health Register (DHR). The DHR is the administrative source for treatment reimbursement for all, both public and private, dentists in Sweden and has registered information from the social insurance system on all dental procedures in Sweden since 2008 (Arwidsson Hansen et al. 2012) . Invasive dental treatments were defined as: 1) scaling and root planing, 2) dentoalveolar surgery and/or tooth extractions, 3) implant surgery, 4) periodontal surgery, and 5) apical surgery. The scaling and root planing treatment were procedures during 1 h. All invasive dental treatments were registered before the outcome in our study and were, at the time of registration, unassociated to our outcome. The time intervals between invasive dental treatments used in analyses comparing case patients and control subjects were 4 and 2 wk, as well as 2 d before the index date (date of case patients' MI). The 4-wk time interval was used as Minassian et al. (2010) showed a slight increased risk of vascular events 4 wk after invasive dental treatments. Two-wk and 2-d intervals were selected to study the possibility of a more acute association.
Data on MI diagnoses and on prior medical events of interest (e.g., diabetes and other cardiovascular diseases [CVDs]) were obtained from registered ICD-10 codes in the IPR. The IPR has had full national coverage since 1987, and validation of the ICD codes registered in the IPR has been confirmed through patient records (Ludvigsson et al. 2011; Socialstyrelsen 2016) . The linkage with the personal identification number by SCB to medical registers has also been validated (Ludvigsson et al. 2009 (Ludvigsson et al. , 2016 . Information on previous CVDs of interest was from ICD-10 codes for heart failure (I.50), atrial fibrillation (I.48), angina pectoris (I.20), and stroke (I.60-I.64 and G.45) registered in the IPR.
Diabetes was defined based on the IPR ICD-10 codes (E.10-E.14) or whether any dispensed prescriptions of any glucose-lowering medication, based on the Anatomical Therapeutic Chemical Classification (ATC) code, A10A or A10B, were registered in the national Swedish Prescribed Drug Register (SPDR) (Wettermark et al. 2007 ). In addition, information on CVD drug treatment was obtained from the SPDR. Four groups were created to present CVD drug treatment: 1) antihypertensive treatment (ATC codes C09A, C09B C09C, C09D, C08C, C03A, C03EA01), 2) statins (C10AA), 3) low-dose aspirin (B01A, C06), and 4) betablockers (C07). Information from ATC codes in the SPDR is highly valid in relation to patients' medical records (Wettermark et al. 2007) .
The national Registry of the Population at SCB provided the information on geographic area of residence, which was grouped in three different regions: 1) North (i.e., counties of Värmland, Dalarna, Gävleborg, Västernorrland, Jämtland, Västerbotten, and Norrbotten), 2) Middle (Stockholm, Uppsala, Södermanland, Östergötland, Örebro, and Västmanland), and 3) South (Jönköping, Kronoberg, Kalmar, Gotland, Blekinge, Skåne, Halland, and Västra Götaland). Subjects' information on socioeconomic status was expressed as income and education and was obtained from SCB in the longitudinal integration database for health insurance and labor market studies (LISA). Education was classified into 3 groups: 1) ≤9 y of education, 2) 10 to 12 y of education, or 3) collage/university or PhD degree. Income was classified into 3 groups: 1) ≤99 kSEK, 2) 100 to 299 kSEK, and 3) ≥300 kSEK per year.
Information on date of death was obtained from the national Cause of Death Register.
Statistical Analysis
Statistical comparisons included the t test for continuous variables and χ 2 tests for categorical variables. Relative risk estimates are given as odds ratios (OR) with 95% CIs and were estimated by conditional logistic regression modeling. In addition to the matching variables (age, sex, and geographical area of residence), adjustments were made for confounders that are well-established risk factors for MI or dental treatment: 1) diabetes, 2) previous CVD, 3) CVD drug treatment, 4) education, and 5) income. We present 2 adjusted models: model 1 (adjusted for matched variables [age, sex, and geographic area of residence]) and model 2 (adjusted for matched variables and diabetes, previous CVD, CVD drug treatment, income, and education). The SAS system statistical software was used (SAS for Windows 9.4; SAS Institute). A 2-sided P value of <5% was considered statistically significant.
Ethical Approval
The regional ethics committee in Stockholm approved the study (Dnr: 2015/279-31/1). The study was conducted according to principles outlined in the Helsinki Declaration.
Results
The mean age was 72.6 ± 13.0 y for case patients and 72.3 ± 13.0 y for control subjects. The proportion of women was 38% among case patients and 39% among control subjects. Case patients more often had diabetes, previous CVD (heart failure, atrial fibrillation, angina pectoris, and stroke) and received more CVD drug treatment (antihypertensive, statins, low-dose aspirin, and beta-blockers) than control subjects. Control subjects had a higher level of education and higher income than case patients (Table 1) .
Dental Treatments 4 wk before the MI Event
The frequency of invasive dental treatments was similar among case patients and control subjects during the 4 wk preceding the MI (1.8% vs. 1.8%), with the exception for implant surgery, which was more common among case patients (Table 2) . Dental examinations, temporary treatments, caries treatment, supragingival scaling/prophylaxis, fillings, root canal treatment, and fixed prosthodontics were performed less often among case patients than control subjects (Table 2) . There was no association between invasive dental treatments performed 4wk before the MI event and the risk of a MI (crude OR = 0.99; 95% CI, 0.92 to 1.06; Table 3 ). Adjusting for confounders did not alter the risk estimate (OR = 0.98; 95% CI, 0.91 to 1.06; Table 3, Fig. 2 ).
Dental Treatments 2 wk and 2 d before the MI Event
The frequency of invasive dental treatments performed 2 wk before the MI event was similar in frequency to those performed 4 wk before the MI (0.9% vs. 1.0%), as were the results of other dental treatments (Table 2 ). There was no association between invasive dental treatments performed 2 wk before the MI event and the risk of an MI (crude OR = 0.94; 95% CI, 0.85 to 1.03; Table 3 ). Adjusting for confounders did not alter the risk estimate (OR = 0.92; 95% CI, 0.83 to 1.02; Table 3 , Fig. 2) .
Invasive dental treatments were performed less often 2 d before the MI event date among case patients than among control subjects (0.1% vs. 0.2%), with the exception for scaling and root planing, which were more common among case patients (Table 2) . Thus, invasive dental treatments performed 2 d preceding the MI event were associated with a decrease in the risk of MI (crude OR = 0.70; 95% CI, 0.54 to 0.90). Adjusting for confounders did not change the risk estimate (OR = 0.71 95% CI, 0.55 to 0.93; Table 3 ).
Stratified Analysis
Stratified analysis in case patients and control subjects with or without a previous CVD diagnosis, CVD drug treatment versus no CVD drug treatment, diabetes versus no diabetes, and high versus low income showed no difference in association between invasive dental treatments and risk of MI (data not shown). 
Discussion
This population-based case-control study, including 51,880 case patients who experienced a first MI, showed no association between MI and invasive dental procedures performed during the 4 wk preceding the MI. This observation remained after adjusting for relevant confounders and was not altered looking at shorter time intervals.
Increased levels of inflammatory markers induce a risk for an acute vascular event (Libby 2013) . These markers may vary in response to infections or to other proinflammatory stimuli, and it is these intermittent changes that have been suggested to increase the risk of a vascular event (Smeeth et al. 2004) . Several studies have shown that invasive dental treatments increase inflammatory markers such as IL-6, tumor necrosis factor α, and CRP within 2 h and possibly last up to 1 wk after the intervention (Loos et al. 2000; Slade et al. 2000 Slade et al. , 2003 Noack et al. 2001; Ide et al. 2004; D'Aiuto et al. 2005 D'Aiuto et al. , 2007 Tonetti et al. 2007; Higashi et al. 2009 ). In a retrospective study by Minassian et al. (2010) , invasive dental treatment increased the risk for a vascular event within 4 wk (MI and stroke). However, this association was not present when the outcome was MI alone. The short-lived duration of the inflammatory response (Loos et al. 2000; Slade et al. 2000 Slade et al. , 2003 Noack et al. 2001; Ide et al. 2004; D'Aiuto et al. 2005 D'Aiuto et al. , 2007 Tonetti et al. 2007; Higashi et al. 2009 ) after an invasive dental treatment could be too short to actually destabilize the fibrous cap and cause an MI. In the present study, we did not find any association to MI, regardless if the time span of the invasive dental treatments was 2 d, 2 wk, or 4 wk prior to the MI. A possible explanation could be that the case patients more often received medical treatment aimed to reduce CVD risk factors already prior to the MI. Statins and low-dose aspirin could have antiinflammatory and antithrombotic effects, respectively, and antihypertensive medications could have reduced hypertensive stress-related reactions and thus could serve as a cardiovascular protective effect during and after the invasive dental treatments (Ridker et al. 2008; Piepoli et al. 2016) . However, stratified analyses in those with CVD, CVD drug treatment, diabetes, or low economic income were performed without finding any associated risk. The slightly higher frequency of dental implant treatment in case subjects does not explain any of the findings and, as the procedure was rare, these findings might be due to chance. One might speculate that the negative association found in undergoing an invasive dental treatment 2 d prior to the MI was due to a so-called protopathic bias (Salas et al. 1999) , meaning that in the days preceding the MI, the case patients were less prone to attend dental health appointments due to fatigue/sickness related to the coming MI.
The finding in the present study, that the case patients had a lower socioeconomic situation and received less dental treatment compared to control subjects, is in line with previous reports showing that low socioeconomic status is associated with worse oral health (Hobdell et al. 2003; Paulander et al. 2003; Buhlin et al. 2005) and with an increased risk for CVD (Albert et al. 2006; Johnson-Lawrence et al. 2013; Kamphuis et al. 2013) .
Strengths and Limitations
A major strength of the present study is that information on outcome was based on data from nationwide Swedish health care registers and comprises all patients diagnosed with an MI (fatal and nonfatal) in Sweden during the study period from 2011 to 2013 (Ludvigsson et al. 2011) . Similarly, the unique DHR (Arwidsson Hansen et al. 2012) , with information on the exposure, has complete coverage of all reimbursed dental procedures in Sweden, which is the majority of all dental procedures in the country. Dental reimbursements require registration in the social insurance system, which is linked to the DHR, and thus imply a high coverage. The registry, however, was initiated in 2008, and scientific validation of the reported variables is so far sparse. The population-based nationwide coverage means that the study includes a large number of subjects and has a high generalizability, for instance, to highincome populations, similar to Sweden, where CVD prevention is high and general oral health is good. In nonrandomized studies, case patients may differ from control subjects on important unmeasured factors; this limitation, however, was decreased by the matching process controlling for age, sex, and geographic area of residence and further by the adjustment for education and income (a proxy for socioeconomic status). Odds ratios with 95% CIs for invasive dental treatments 4 and 2 wk and 2 d before the case patients' myocardial infarction diagnosis and the corresponding index date for control subjects shown for all case patients and control subjects.
Conclusion
This case-control study did not support the hypothesis of an increased association between incidence of a first MI and recent invasive dental treatment.
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